Omnicell to Present at Piper Jaffray 19th Annual Health Care Conference

Tuesday, November 20, 2007 General News J E 4
MOUNTAIN VIEW, Calif., Nov. 19 Omnicell, Inc.(Nasdaq: OMCL) a leading provider of systems and software solutions targetingpatient safety and operational efficiency in healthcare facilities, todayannounced that Randall A. Lipps, chairman, president & CEO and Rob Seim, vicepresident & CFO will present at the Piper Jaffray 19th Annual Health CareConference at The Pierre Hotel, New York, NY. The Omnicell presentation isscheduled to begin at 12:00 p.m. on Wednesday, November 28, 2007.

A link to the audio-webcast of the live presentation may be accessed byvisiting

Following the conference, a replay of the audio-webcast will be archivedfor 30 days on the site.

About Omnicell

Omnicell, Inc. (Nasdaq: OMCL) is a leading provider of systems andsoftware solutions targeting patient safety and operational efficiency inhealthcare facilities. Since 1992, Omnicell has worked to enhance patientsafety and allow clinicians to spend more time with their patients.

Omnicell's medication-use product line includes solutions for the centralpharmacy, nursing unit, operating room, and patient bedside. Solutions rangefrom large central pharmacy "smart inventory" carousels to small handhelddevices. From the point at which a medication arrives at the receiving dock tothe time it is administered, Omnicell systems store it, package it, bar codeit, order it, issue it, and provide information and controls on its use andreorder.

Our supply product lines provide a healthcare institution with fast,effective control of costs, capture of charges for payer reimbursement, andtimely reorder of supplies. Products range from high-security closed-cabinetsystems and software to open-shelf and combination solutions in the nursingunit, cath lab and operating room. For more information, visit

SOURCE Omnicell, Inc.


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
FDA Accepts Ranexa(R) sNDA and NDA for Filing
Your Hearing May be at Risk, Says Harvard Men's He...